These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31581115)

  • 1. Response to diagnosis of pre-diabetes in socioeconomically deprived areas: a qualitative study.
    Twohig H; Hodges V; Hobbis C; Mitchell C
    BJGP Open; 2019 Oct; 3(3):. PubMed ID: 31581115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences on Patient Uptake of and Engagement With the National Health Service Digital Diabetes Prevention Programme: Qualitative Interview Study.
    Ross J; Cotterill S; Bower P; Murray E
    J Med Internet Res; 2023 Feb; 25():e40961. PubMed ID: 36853751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of demographic, health and psychosocial factors on patient uptake of the English NHS diabetes prevention programme.
    Reeves D; Woodham AA; French D; Bower P; Holland F; Kontopantelis E; Cotterill S
    BMC Health Serv Res; 2023 Apr; 23(1):352. PubMed ID: 37041541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators of self-management of diabetes amongst people experiencing socioeconomic deprivation: A systematic review and qualitative synthesis.
    Woodward A; Walters K; Davies N; Nimmons D; Protheroe J; Chew-Graham CA; Stevenson F; Armstrong M
    Health Expect; 2024 Jun; 27(3):e14070. PubMed ID: 38751247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of decisions to attend a national diabetes prevention programme from people living in a socioeconomically deprived area.
    Begum S; Povey R; Ellis N; Gidlow C; Chadwick P
    Diabet Med; 2022 Jul; 39(7):e14804. PubMed ID: 35122316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the design of the NHS Diabetes Prevention Programme intervention have fidelity to the programme specification? A document analysis.
    Hawkes RE; Cameron E; Bower P; French DP
    Diabet Med; 2020 Aug; 37(8):1357-1366. PubMed ID: 31808578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes prevention at scale: Narrative review of findings and lessons from the DIPLOMA evaluation of the NHS Diabetes Prevention Programme in England.
    Bower P; Soiland-Reyes C; Heller S; Wilson P; Cotterill S; French D; Sutton M
    Diabet Med; 2023 Nov; 40(11):e15209. PubMed ID: 37634235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The community pharmacy setting for diabetes prevention: A mixed methods study in people with 'pre-diabetes'.
    Katangwe T; Family H; Sokhi J; Kirkdale CL; Twigg MJ
    Res Social Adm Pharm; 2020 Aug; 16(8):1067-1080. PubMed ID: 31734102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NHS Diabetes Prevention Programme: an observational study of service delivery and patient experience.
    Hawkes RE; Cameron E; Cotterill S; Bower P; French DP
    BMC Health Serv Res; 2020 Nov; 20(1):1098. PubMed ID: 33246460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and Facilitators to Real-world Implementation of the Diabetes Prevention Program in Large Healthcare Systems: Lifestyle Coach Perspectives.
    Halley MC; Petersen J; Nasrallah C; Szwerinski N; Romanelli R; Azar KMJ
    J Gen Intern Med; 2020 Jun; 35(6):1684-1692. PubMed ID: 32291720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current practices, facilitators, and barriers experienced by program providers implementing the National Diabetes Prevention Program in Los Angeles County.
    Green G; DeFosset AR; Sivashanmugam M; Mosst J; Kuo T
    Transl Behav Med; 2021 Mar; 11(2):430-440. PubMed ID: 32293679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative evaluation of the national rollout of a diabetes prevention programme in England.
    Brunton L; Soiland-Reyes C; Wilson P
    BMC Health Serv Res; 2023 Sep; 23(1):1043. PubMed ID: 37773125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the NHS Diabetes Prevention Programme Intervention Delivered as Planned? An Observational Study of Fidelity of Intervention Delivery.
    French DP; Hawkes RE; Bower P; Cameron E
    Ann Behav Med; 2021 Oct; 55(11):1104-1115. PubMed ID: 33580647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing and ensuring fidelity of the nationally implemented English NHS diabetes prevention programme: lessons learned for the implementation of large-scale behaviour change programmes.
    Hawkes RE; Miles LM; Bower P; Cotterill S; French DP
    Health Psychol Behav Med; 2022; 10(1):498-513. PubMed ID: 35646476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could diabetes prevention programmes result in the widening of sociodemographic inequalities in type 2 diabetes? Comparison of survey and administrative data for England.
    Chatzi G; Whittaker W; Chandola T; Mason T; Soiland-Reyes C; Sutton M; Bower P
    J Epidemiol Community Health; 2023 Sep; 77(9):565-570. PubMed ID: 37353312
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.